ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.59
      -0.03%
      Bitcoin
      93,206.00
      -1.36%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC

      6. Orogen Royalties Inc (QX) (OGNRF) Quote

      Orogen Royalties Inc (QX)

      Orogen Royalties Inc (QX) (OGNRF)

      USOTC
      1.01
      0.0667
      (7.07%)
      Closed January 13 4:00PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.01
      Bid
      0.9695
      Ask
      1.07
      Volume
      351,890
      0.945 Day's Range 1.02
      0.46 52 Week Range 1.275
      Market Cap
      203.523M
      Previous Close
      0.9433
      Open
      0.945
      Last Trade
      200
      @
      1.01
      Last Trade Time
      Financial Volume
      $ 347,133
      VWAP
      0.986482
      Average Volume (3m)
      147,031
      Shares Outstanding
      201,508,022
      Dividend Yield
      -
      PE Ratio
      97.35
      Earnings Per Share (EPS)
      0.02
      Revenue
      7.83M
      Net Profit
      3.04M

      About Orogen Royalties Inc (QX)

      Sector
      Miscellaneous Metal Ores,nec
      Industry
      Unit Inv Tr, Closed-end Mgmt
      Website
      www.orogenroyalties.com
      Headquarters
      Vancouver, British Columbia, Can
      Founded
      2009
      Orogen Royalties Inc (QX) is listed in the Miscellaneous Metal Ores sector of the OTCMarkets with ticker OGNRF. The last closing price for Orogen Royalties (QX) was $0.94. Over the last year, Orogen Royalties (QX) shares have traded in a share price range of $ 0.46 to $ 1.275.

      Orogen Royalties (QX) currently has 201,508,022 shares outstanding. The market capitalization of Orogen Royalties (QX) is $190.08 million. Orogen Royalties (QX) has a price to earnings ratio (PE ratio) of 97.35.

      Ask ADVFN Intelligence (AI)

      OGNRF Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.06186.517612318080.94821.020.9265804430.95636791CS
      40.077.446808510640.941.020.871258970.91917638CS
      12-0.195-16.18257261411.2051.2750.871470311.00311645CS
      260.1852522.46135192480.824751.2750.81228921.01413726CS
      520.511102.4048096190.4991.2750.461116810.88990616CS
      1560.6522182.2806036890.35781.2750.2672833460.60935665CS
      2600.73260.7142857140.281.2750.0255847540.5593584CS

      OGNRF - Frequently Asked Questions (FAQ)

      What is the current Orogen Royalties (QX) share price?
      The current share price of Orogen Royalties (QX) is $ 1.01
      How many Orogen Royalties (QX) shares are in issue?
      Orogen Royalties (QX) has 201,508,022 shares in issue
      What is the market cap of Orogen Royalties (QX)?
      The market capitalisation of Orogen Royalties (QX) is USD 190.08M
      What is the 1 year trading range for Orogen Royalties (QX) share price?
      Orogen Royalties (QX) has traded in the range of $ 0.46 to $ 1.275 during the past year
      What is the PE ratio of Orogen Royalties (QX)?
      The price to earnings ratio of Orogen Royalties (QX) is 97.35
      What is the cash to sales ratio of Orogen Royalties (QX)?
      The cash to sales ratio of Orogen Royalties (QX) is 37.89
      What is the reporting currency for Orogen Royalties (QX)?
      Orogen Royalties (QX) reports financial results in CAD
      What is the latest annual turnover for Orogen Royalties (QX)?
      The latest annual turnover of Orogen Royalties (QX) is CAD 7.83M
      What is the latest annual profit for Orogen Royalties (QX)?
      The latest annual profit of Orogen Royalties (QX) is CAD 3.04M
      What is the registered address of Orogen Royalties (QX)?
      The registered address for Orogen Royalties (QX) is 1015-789 WEST PENDER STREET, VANCOUVER, BRITISH COLUMBIA, V6C 1H2.
      What is the Orogen Royalties (QX) website address?
      The website address for Orogen Royalties (QX) is www.orogenroyalties.com
      Which industry sector does Orogen Royalties (QX) operate in?
      Orogen Royalties (QX) operates in the UNIT INV TR, CLOSED-END MGMT sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CRGPCalissio Resources Group Inc (CE)
      $ 0.0004
      (39,900.00%)
      		20k
      SMMESmartMetric Inc (PK)
      $ 0.0001
      (9,900.00%)
      		1.25M
      NEOMNeoMedia Technologies Inc (CE)
      $ 0.0001
      (9,900.00%)
      		534.97k
      RRGIReality Racing Inc (CE)
      $ 0.0001
      (9,900.00%)
      		209k
      ELIQQElectriq Power Holdings Inc (CE)
      $ 0.0001
      (9,900.00%)
      		290
      IBKKFImining Technologies Inc (CE)
      $ 0.000001
      (-100.00%)
      		100
      EGIOQEdgio Inc (CE)
      $ 0.000001
      (-99.99%)
      		905
      CYBFCyberfort Software Inc (CE)
      $ 0.000001
      (-99.88%)
      		20k
      CHMJDWaverunner Capital Inc
       0.0045
      (-99.40%)
      		106
      CCTLCoin Citadel (PK)
      $ 0.000001
      (-99.00%)
      		108k
      HMBLHUMBL Inc (PK)
      $ 0.0009
      (0.00%)
      		359.72M
      GRLFGreen Leaf Innovations Inc (PK)
      $ 0.00015
      (50.00%)
      		194.9M
      AITXArtificial Intelligence Technology Solutions Inc (PK)
      $ 0.00375
      (-1.32%)
      		188.36M
      TSOITherapeutic Solutions International Inc (PK)
      $ 0.0002
      (-33.33%)
      		168.26M
      PHILPHI Group Inc (PK)
      $ 0.00025
      (-16.67%)
      		129.87M

      Discussion

      View Full Feed
      Hi_Lo Hi_Lo 7 minutes ago
      Lol!! I want profits!! What you want helps me in no way!!
      Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents scamming pumpers and liars like you from making profits by creating bagholders here. And that's part of my goal - and to h
      BCAP
      DiamondHealer95 DiamondHealer95 11 minutes ago
      What do you expect and how can you back your thoughts? Thanks
      KBLB
      DiamondHealer95 DiamondHealer95 17 minutes ago
      I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

      Also, in my Arby's voice "I have the
      KBLB
      DiamondHealer95 DiamondHealer95 21 minutes ago
      We've invested similarly
      KBLB
      sunspotter sunspotter 32 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 42 minutes ago
      Marc loved your ides
      tinojax tinojax 44 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 46 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 1 hour ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 1 hour ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 1 hour ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 1 hour ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 1 hour ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 1 hour ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 1 hour ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 1 hour ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 2 hours ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 2 hours ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX

      Your Recent History

      USOTC
      OGNRF
      Orogen Royalties (QX)
      USOTC
      OLCLY
      Oriental Land (PK)
      LSE
      SM39
      Nationwde 42
      LSE
      HGEN
      Hydrogenone Capital Growth
      USOTC
      ATMFF
      Atmofizer Technologies (PK)
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads